Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abbvie, Acurx, Clear Scientific, Disc Medicine, FOXG1 Research Foundation, JCR, Kexing, Medipal, Umoja, Vicore.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Outlook, Roche, Uroviu, Zenflow, Zoll.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Applied, Bioarctic, Dyne, Eisai, Johnson & Johnson, Kedrion, Novo Nordisk, Nrx, Outlook.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Biogen, Burning Rock.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fluidai Medical, Guardant Health.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abbvie, Amneal, Crinetics, Eli Lilly, Regeneron, Sanofi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiac Biotech, Clearnote Health, Heamosonics, Marginum, Mediwound, Zimmer Biomet.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Arialys, Biogen, Biostar, Eisai, Nrx, Vertex.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biolinq.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Artios, Astrazeneca, Bioartic, Biogen, Cure Rare Disease, Daiichi Sankyo.